At MedPharm, our Process Development, Quality by Design (QbD), and Scale-Up services offer pharmaceutical companies a structured, data-driven approach to optimizing drug manufacturing processes. We ensure regulatory compliance and facilitate seamless transitions from small-scale development to commercial production.
By implementing QbD principles, process validation strategies, and advanced scale-up methodologies, we guarantee that topical and transdermal drug products achieve batch-to-batch consistency, stability, and readiness for regulatory approval.
With scientifically guided process development, QbD implementation, and seamless scale-up strategies, MedPharm ensures that your topical and transdermal drug formulations transition from early-stage development to full-scale manufacturing.
Explore Our Process Development Solutions:
Turning Scientific Insights into Scalable, High-Performance Drug Products At MedPharm, Characterization & Optimization is the critical phase where formulation science meets process precision. This step enables our scientists to refine every aspect of your drug product—transforming early-stage concepts into scalable, stable, and therapeutically effective solutions.
Identification of critical process parameters (CPPs) and quality attributes Optimization of mixing, homogenization, emulsification, and drug dispersion techniques Validation of excipient interactions for stability and efficacy Implementation of in-process controls (IPCs) for real-time product quality monitoring
Risk-based approach to process and formulation design ICH Q8, Q9, and Q10-compliant methodology for process understanding Design of Experiments (DoE) to identify optimal process conditions Regulatory-aligned process validation to ensure long-term consistency
CMC (Chemistry, Manufacturing & Controls) documentation for IND, NDA, and ANDA filings GMP-compliant process development ensuring adherence to global regulatory standards Comprehensive process validation reports for regulatory submissions Risk management strategies to address scale-up deviations and compliance gaps
Pilot-scale and clinical-scale batch production for process refinement Identification of scale-up challenges to ensure seamless technology transfer Batch-to-batch reproducibility assessments for regulatory filings Equipment and facility compatibility assessments for commercial production
Bridging Innovation and Manufacturing with Confidence In pharmaceutical development, exceptional formulations require more than just scientific brilliance—they need a well-structured and strategic path to commercial scale. At MedPharm, our Scale-Up & Technology Transfer services are specifically designed to convert your lab-scale innovations into full-scale production efficiently, accurately, and with regulatory assurance.